SI
SI.US Shoulder Innovations, Inc.
- Market cap
- USD 430M
- P/E
- 18.5x
- P/B
- 3.61x
- ROE
- -28.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SI.US undervalued?
Graham numberSI.US trades 72.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shoulder Innovations, Inc. fundamental analysis
No fundamental analysis for Shoulder Innovations, Inc. yet.
Shoulder Innovations, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. engages in the provision of medical devices. It focuses on transforming the shoulder surgical care market. It also offers advanced implant systems for shoulder arthroplasty. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Full company profileShoulder Innovations, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shoulder Innovations, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 19.3M | 31.6M | 47.3M | 66.8M |
| Gross Profit | 15.3M | 24.3M | 36.2M | 52.2M |
| Operating Income | -10.9M | -14.7M | -26.3M | -35.5M |
| EBITDA | -10.3M | -12.1M | -37.1M | -30.2M |
| Net Income | -12.7M | -15.6M | -40.4M | -34.1M |
| EPS | -0.64 | -0.78 | -1.96 | -1.64 |
| Balance Sheet | ||||
| Total Assets | 54.3M | 43.1M | 170M | 146M |
| Total Liabilities | 94.0M | 97.8M | 29.2M | 27.1M |
| Shareholders' Equity | -39.7M | -54.7M | 141M | 118M |
| Cash & Short-term Investments | 32.8M | 15.0M | 124M | 92.3M |
| Total Debt | 14.5M | 14.7M | 15.0M | 14.9M |
| Cash Flow | ||||
| Operating Cash Flow | -13.1M | -14.1M | -28.6M | -34.9M |
| Capital Expenditure | 2.75M | 4.02M | 7.41M | 7.30M |
| Free Cash Flow | -15.9M | -18.2M | -36.0M | -42.2M |
| Ratios | ||||
| ROE | - | - | -28.7% | -28.8% |
| ROA | -23.3% | -36.3% | -23.8% | -23.4% |
| Net Profit Margin | -65.7% | -49.4% | -85.3% | -51.1% |
| Debt to Equity | - | - | 0.11x | 0.13x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shoulder Innovations, Inc. dividends
Shoulder Innovations, Inc. has not paid dividends in the last 3 fiscal years.
Who owns Shoulder Innovations, Inc.
Top funds holding SI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Select Medical Tech and Devcs | 948K | 4.53% | 0.00% | Sep 2026 |
| Fidelity Small Cap Growth | 778K | 3.72% | 0.00% | Aug 2026 |
| Fidelity Select Health Care | 545K | 2.61% | 0.00% | Aug 2026 |
| Fidelity Balanced | 463K | 2.21% | -0.02% | Aug 2026 |
| Fidelity Small Cap Growth K6 | 388K | 1.85% | 0.00% | Aug 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 322K | 1.54% | 0.00% | Sep 2026 |
| Fidelity Advisor Health Care I | 311K | 1.49% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 282K | 1.35% | 0.00% | Oct 2026 |
| Strategic Advisers Fidelity US TtlStk | 199K | 0.95% | 0.00% | Sep 2026 |
| Calamos Timpani Small Cap Growth I | 190K | 0.91% | 0.00% | Sep 2026 |
| Heptagon Driehaus US Micro Cap Eq C$ Acc | 120K | 0.57% | 0.00% | Sep 2026 |
| Fidelity Small Cap Index | 115K | 0.55% | 0.00% | Aug 2026 |
| iShares Russell 2000 Value ETF | 107K | 0.51% | 0.00% | Oct 2026 |
| Fidelity VIP Health Care Initial | 89.6K | 0.43% | +456.22% | Sep 2026 |
| JPMorgan Small Cap Value I | 73.4K | 0.35% | -2.06% | Sep 2026 |
| Strategic Advisers U.S. Total Stock | 72.8K | 0.35% | 0.00% | Sep 2026 |
| Vanguard Russell 2000 ETF | 68.5K | 0.33% | +13.70% | Sep 2026 |
| AST Small-Cap Equity Portfolio | 67.3K | 0.32% | +5.15% | Sep 2026 |
| Fidelity VIP Balanced Initial | 63.0K | 0.30% | 0.00% | Aug 2026 |
| Fidelity Extended Market Index | 53.4K | 0.26% | +102.67% | Sep 2026 |
Top institutions holding SI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| FMR Inc | 3.67M | 17.56% | -2.92% | Jun 2026 |
| BlackRock Inc | 638K | 3.05% | +14.81% | Jun 2026 |
| Sectoral Asset Management Inc | 430K | 2.06% | +0.00% | Sep 2026 |
| Vanguard Capital Management, LLC | 392K | 1.87% | -5.15% | Jun 2026 |
| TimesSquare Capital Management, LLC | 351K | 1.68% | +17.61% | Sep 2026 |
| KCM Capital Inc | 300K | 1.43% | +757.14% | Jun 2026 |
| Driehaus Capital Management LLC | 254K | 1.21% | 0.00% | Jun 2026 |
| Roubaix Capital, LLC | 230K | 1.10% | -9.93% | Sep 2026 |
| Parkman Healthcare Partners LLC | 226K | 1.08% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 200K | 0.95% | +8.63% | Jun 2026 |
| CM Management, LLC | 130K | 0.62% | -10.34% | Sep 2026 |
| JPMorgan Chase & Co | 124K | 0.59% | -4.80% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 117K | 0.56% | -25.58% | Jun 2026 |
| State Street Corp | 115K | 0.55% | +23.18% | Jun 2026 |
| HighTower Advisors, LLC | 103K | 0.49% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 86.3K | 0.41% | 0.00% | Jun 2026 |
| Walleye Trading Advisors, LLC | 86.2K | 0.41% | +1.14% | Jun 2026 |
| Schonfeld Strategic Advisors LLC | 77.7K | 0.37% | 0.00% | Jun 2026 |
| Northern Trust Corp | 71.3K | 0.34% | +11.28% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 70.3K | 0.34% | +15.31% | Jun 2026 |
Shoulder Innovations, Inc. company profile
- Company name
- Shoulder Innovations, Inc.
- Ticker
- SI.US
- Exchange
- USA Stocks
- Listed since
- Jul 31, 2025
- Sector
- -
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- Website
- -
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. engages in the provision of medical devices. It focuses on transforming the shoulder surgical care market. It also offers advanced implant systems for shoulder arthroplasty. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.